| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2019 ( Subtotal = -$1,004,499 ) |
| | 2019 | 2016 | CAPRICOR, INC. | 8840 WILSHIRE BLVD 2ND FL | BEVERLY HILLS | CA | 90211-2606 | LOS ANGELES | USA | UT2HL131226 | The Allogeneic Heart Stem Cell Trial in Hypoplastic Left Heart Syndrome Patients | 000 | 1 | NIH | 3/26/2019 | -$1,004,499 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | CAPRICOR, INC. | 8840 WILSHIRE BLVD 2ND FL | BEVERLY HILLS | CA | 90211-2606 | LOS ANGELES | USA | UT2HL131226 | The Allogeneic Heart Stem Cell Trial in Hypoplastic Left Heart Syndrome Patients | 000 | 1 | NIH | 8/30/2018 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $1,683,381 ) |
| | 2016 | 2016 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | UT2HL131226 | The Allogeneic Heart Stem Cell Trial in Hypoplastic Left Heart Syndrome Patients | 000 | 1 | NIH | 9/14/2016 | $1,683,381 |
|
| Issue Date FY: 2015 ( Subtotal = $880,760 ) |
| | 2015 | 2015 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | R44HL095203 | Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy | 000 | 6 | NIH | 7/8/2015 | $880,760 |
|
| Issue Date FY: 2014 ( Subtotal = $998,765 ) |
| | 2014 | 2014 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | R44HL095203 | Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy | 000 | 5 | NIH | 6/24/2014 | $998,765 |
|
| Issue Date FY: 2013 ( Subtotal = $999,912 ) |
| | 2013 | 2013 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | R44HL095203 | Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy | 001 | 4 | NIH | 8/21/2013 | $999,912 |
| | 2013 | 2012 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | R44HL095203 | Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy | 000 | 3 | NIH | 8/19/2013 | $0 |
| | 2013 | 2010 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | RC3HL103356 | SAFETY AND EFFICACY OF ALLOGENEIC CARDIOSPHERE-DERIVED STEM CELLS AFTER MI | 000 | 1 | NIH | 5/3/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $425,410 ) |
| | 2012 | 2012 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | R44HL095203 | Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy | 001 | 3 | NIH | 2/29/2012 | $425,410 |
| | 2012 | 2011 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | R44HL095203 | Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy | 000 | 2 | NIH | 11/3/2011 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $397,217 ) |
| | 2011 | 2011 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | R44HL095203 | Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy | 000 | 2 | NIH | 2/24/2011 | $397,217 |
|
| Issue Date FY: 2010 ( Subtotal = $2,993,268 ) |
| | 2010 | 2010 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | RC3HL103356 | SAFETY AND EFFICACY OF ALLOGENEIC CARDIOSPHERE-DERIVED STEM CELLS AFTER MI | 002 | 1 | NIH | 7/12/2010 | $0 |
| | 2010 | 2010 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | RC3HL103356 | SAFETY AND EFFICACY OF ALLOGENEIC CARDIOSPHERE-DERIVED STEM CELLS AFTER MI | 001 | 1 | NIH | 6/24/2010 | -$2,993,268 |
| | 2010 | 2010 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | RC3HL103356 | SAFETY AND EFFICACY OF ALLOGENEIC CARDIOSPHERE-DERIVED STEM CELLS AFTER MI | 001 | 1 | NIH | 6/24/2010 | $2,993,268 |
| | 2010 | 2010 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | RC3HL103356 | SAFETY AND EFFICACY OF ALLOGENEIC CARDIOSPHERE-DERIVED STEM CELLS AFTER MI | 000 | 1 | NIH | 5/13/2010 | $2,993,268 |
| | 2010 | 2009 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | R44HL095203 | Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy | 000 | 1 | NIH | 6/25/2010 | $0 |
| | 2010 | 2009 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | R44HL095203 | Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy | 001 | 1 | NIH | 8/10/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $124,791 ) |
| | 2009 | 2009 | CAPRICOR INC | 8700 BEVERLY BOULEVARD | LOS ANGELES | CA | 90048 | LOS ANGELES | USA | R44HL095203 | Safety of Allogeneic Cardiosphere-Derived Cells for Dilated Cardiomyopathy | 000 | 1 | NIH | 8/24/2009 | $124,791 |
|
|
